Immunoprecise Antibodies
17 hedge funds and large institutions have $4.44M invested in Immunoprecise Antibodies in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
3
Calls
$1.12M
Puts
$101K
Net Calls
+$1.02M
Net Calls Change
-$135K
Top Buyers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$22.4K |
2 |
ISL
2
Ingalls & Snyder LLC
New York
|
$3.14M |
3 |
![]()
3
Group One Trading
Chicago,
Illinois
|
$4.68K |